Company News: Dr Reddy’s Laboratories

Dr Reddy’s Laboratories has received an establishment inspection report (EIR) from the US health regulator following audit of its UK facility. The USFDA issues an EIR to the establishment that is the subject of an FDA or FDA-contracted inspection when the agency decides to close the inspection. In September last year, the US Food and Drug Administration had made three observations after inspecting Dr Reddy’s Laboratories’ API Mirfield (United Kingdom) plant. Shares of Dr Reddy’s Laboratories gained 1 per cent at ₹2,156.25 on the BSE.